| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |